Showing results (171-180 of 192) with videos related to
Sort By:
Pageof 20
JCO Precision Oncology|September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II GliomaJessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.The New England Journal of Medicine|December 24, 2010
NFKBIA deletion in glioblastomasMarkus Bredel, Denise M Scholtens, Ajay K Yadav, et al.JAMA Oncology|June 30, 2018
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 TrialErica H Bell, Peixin Zhang, Barbara J Fisher, et al.Neuro-Oncology|September 21, 2014
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastomaMarta Penas-Prado, Kenneth R Hess, Michael J Fisch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2025
Dual Immune Check Point Blockade in <i>MGMT</i>-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical TrialAndrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto, et al.Nature Genetics|October 11, 2016
The genomic landscape of schwannomaSameer Agnihotri, Shahrzad Jalali, Mark R Wilson, et al.Acta Neuropathologica|April 9, 2025
Diffuse astrocytoma, AYA-type, frequently MAPK-altered: report of 45 patientsOmkar Singh, Christopher Dampier, Zied Abdullaev, et al.Journal of the National Cancer Institute|December 16, 2015
TERT Promoter Mutations and Risk of Recurrence in MeningiomaFelix Sahm, Daniel Schrimpf, Adriana Olar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of originAlbert Lai, Samir Kharbanda, Whitney B Pope, et al.Neuro-Oncology|June 4, 2011
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumorsAndrew B Lassman, Fabio M Iwamoto, Timothy F Cloughesy, et al.Pageof 20